Presented by Rich Chesney at Carevoyant 2015. To understand how the healthcare delivery landscape is changing for home health and hospice and provide self-assessment tools to gauge future growth and opportunities.
2. AGENDA
Purpose
Speaker Background
Environmental Context
4 Survival Test questions
Home Health
Hospice
Implications/Conclusions
3. PURPOSE
Understand how the healthcare delivery landscape is
changing for home health and hospice
Provide a self-assessment tool for organizations to
gauge the prospects for future success in home health
and hospice
Outline next steps for organizations based on results
of tool
4. SPEAKER BACKGROUND
Over 20 years in home care
35 years of experience in planning and marketing
MBA from the Sloan School of Massachusetts Institute
of Technology
President, Healthcare Market Resources,
5. HEALTHCARE MARKET RESOURCES
Leading market research firm serving post-acute
Helps home health agencies, hospices and SNF’s better
understand their market, competitors and referral
sources
Clients use our data in strategic/market planning,
benchmarking, sales targeting and key account
development
Referral data on hospital, SNF’s and MD’s
7. CHANGING LANDSCAPE
Pay for Value, not Volume
Demonstration projects
Accountable Care Organizations-Population Health
Management
“Capitation” thru voluntary and mandatory bundled
payments
Performance Incentives/Penalties
8. CHANGING LANDSCAPE
Narrowing provider referral lists
Hospitals
SNF’s
Physicians
More data transparency & differentiation
Re-admission rates
STAR ratings
Increased regulatory scrutiny
Drive unnecessary care and costs out of system
10. QUESTION 1 HOME HEALTH
Can we grow organically?
How mature is my market?
How concentrated is my market?
Is there an opportunity to shift post-acute site of care
mix?
Can we increase revenue per patient-less LUPA’s, higher
case weight & more re-certs
11. QUESTION 1 HOSPICE
Can we grow organically?
How mature is my market?
How concentrated is my market?
What is median LOS for my market?
What is my market’s non-cancer mix?
What is my market’s site of care mix?
What is utilization amongst underserved population?
Can my hospice use palliative care to capture patients
earlier in the disease process?
What is managed care penetration?
12. QUESTION 2 HOME HEALTH
What is my role within post-acute networks?
How big is the post-acute market?
How dominant are captive agencies at their own
facilities?
How will proposed bundle payments for joint
replacements affect referral patterns in my market and
at specific local hospitals?
How does your organization compare to its competitors
to be asked to join these network(s)?
Will hospitals monitor referrals of owned MD’s?
13. QUESTION 2 HOSPICE
What is my role within post-acute networks?
How big is the post-acute market?
How dominant are captive agencies at their own
facilities?
Where do the hospitals in your market stand on
bundled payments, ACO’s & value-based purchasing
metrics-mortality rates, re-admission rates and per
beneficiary spending?
Is there inpatient & palliative care capacity to limit end
of life expenditures?
14. QUESTION 3 HOME HEALTH
What is impact of reimbursement changes on my
agency, market and competitors?
Shift in weighting for therapy cases
Dual eligible demonstration project
Limits on re-cert rates
Cost re-basing & sequestration
IMPACT Act
Value-based purchasing for Home Health
ICD-10 Coding Transition
15. QUESTION 3 HOSPICE
What is impact of reimbursement changes on hospice?
Two tiered rates beginning 1/1/2016 under and over 60
days for routine home care(RHC)
Added reimbursement in last 7 days for professional visits
to RHC patients
Compare LOS mix versus competitors to estimate impact
Hospices over the cap most affected(-5.4%) margins ; current
profits could be being re-directed to prior yr repayment plans.
MedPAC recommendation to move hospice to managed
care
16. QUESTION 4 HOME HEALTH
Is your agency cost efficient?
Does it benchmark performance against local
competitors?
Does it optimize visit levels by HHRG by discipline
Does it analyze why LUPA’s occurred?
Does it have practices in place to optimize episode
management
Frontloading chronic disease, joint replacement and surgical
aftercare patients
Appropriate use of nursing in therapy cases?
Evaluation of therapy need based on clinical triggers
17. QUESTION 4 HOSPICE
Is your hospice cost efficient?
Compare visit levels per patient per week by discipline to
competitors
New quality measure as visits in 2 days prior to death
Visits correlate to patient satisfaction levels, particularly
near end-of-life(EOL)
Preponderance of short-stay patients
18. IMPLICATIONS
Need to get a passing score(3 out of 4) to have a chance
to survive long term
Cannot rest on laurels; bar will get higher
Failing scores seriously need to consider HARD
options
Merger
Sale
Phase-out
Passing scores or the prospect of one means you need
to making changes NOW
19. CONCLUSIONS
Value-based purchasing is here to stay across ALL
segments
Hospitals will dominate post-acute landscape
MD’s and insurers will focus on pre-acute or community-
based referrals
REFERRAL LISTS WILL SHORTEN
Hospices and HH agencies will need to differentiate
themselves with outcomes/data
Low barriers to entry will prompt large post-acute
providers and short-term acute hospitals to add captive
HH and hospice capacity
20. FREE OFFER
Start the process by answering Question 1 or 4
Need to understand the maturity of your market by
understanding utilization level of home health and/or
hospice
Need to understand if appropriate visit level are bing
performed by HHRG
Hand business card and indicate on the back as to
which report you want
21.
22. CONTACT INFORMATION
Rich Chesney
President, Healthcare Market Resources
1133 Dundee Drive, Ste. 100, Dresher, PA 19025
rchesney@healthmr.com
215.657.7373
MARKET DECISIONS BASED ON DATA, NOT
PERCEPTIONS